SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Growth stocks with Value
CNBX 0.000300-25.0%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: zx3/18/2016 12:13:32 PM
   of 3145
 
Acetaminophen did not help arthritis pain.
The clinical trials tested seven non-steroidal anti-inflammatory drugs, or NSAIDs: naproxen (Aleve), ibuprofen (Advil), celecoxib (Celebrex), lumiracoxib (Prexige) rofecoxib (Vioxx), diclofenac (Voltaren) and etoricoxib (Arcoxia). The researchers found that 150 milligrams a day of diclofenac was the most effective for short-term pain relief. Close behind were 60 milligrams a day of etoricoxib and 25 milligrams a day of rofecoxib.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext